Barinthus Biotherapeutics
BRNS
#9836
Rank
C$39.11 M
Marketcap
$0.97
Share price
-11.43%
Change (1 day)
-80.49%
Change (1 year)

Operating Margin for Barinthus Biotherapeutics (BRNS)

Operating Margin as of April 2025 (TTM): -409.02%

According to Barinthus Biotherapeutics's latest financial reports and stock price the company's current Operating Margin is -409.02%. At the end of 2024 the company had an Operating Margin of -409.03%.

Operating Margin history for Barinthus Biotherapeutics from 2020 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-409.03%-95.71%
2023-9,541.40%-501898.88%
20221.90%-100.01%
2021-19,082.09%5057.23%
2020-370.01%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.